Clinical Trial Update: A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating GRC 54276 in participants with advanced solid tumors and lymphomas is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• GRC 54276 (GRC-54276)

Snippet

Sponsor: Glenmark Specialty S.A. | Conditions: Advanced Solid Tumor, Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING